SLE & APS [EULAR HL 2023] SLE & APS 30 Jun 202330 Jun 2023 Author: Mert Oztas Schett et al. (OP0141) presents the long-term clinical efficacy and safety data of the first seven SLE patients (median follow up of 13 months) receiving autologous CD19-directed CAR-T cell…
SLE & APS SLE & APS 29 May 202329 May 2023 Daliya Pencheva Daliya is a rheumatology resident at the University Hospital “St. Ivan Rilski”, Sofia, Bulgaria. Her major interests are systemic lupus erythematosus, quality of life, patient-reported outcome measures, treat-to-target therapy.…